🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A single-centre Phase 1b study to assess the safety, tolerability, pharmaco...
Status
Completed
Location
Q-Pharm
Start Date
2018-04-23
Trial ID
NCT03542149
Piperaquine tablets (coated) + OZ439 granules + TPGS granules will be co-ad...
Status
Completed
Location
Richmond Pharmacology Limited
Start Date
2013-04
Trial ID
NCT01853475
Treatments Being Tested
The purpose of this study is to determine the bioavailability of nanopartic...
Status
Completed
Location
Quotient Clinical
Start Date
2012-11
Trial ID
NCT01732588
Treatments Being Tested
Part A -Cohort 1 DSM265 will be administered as a single dose (400 mg). Fo...
Status
Terminated
Location
Q-Pharm Clinics
Start Date
2015-10
Trial ID
NCT02573857
This is a single-centre, controlled, open label study using P. falciparum-i...
Status
Completed
Location
Q-Pharm Clinics
Start Date
2015-04
Trial ID
NCT02431650
Treatments Being Tested
This study is designed to assess prototype formulations compared to the aqu...
Status
Completed
Location
AMREP Centre for Clinical Studies
Start Date
2012-04
Trial ID
NCT01383096
A randomised, double-blind single-dose study to determine the efficacy, saf...
Status
Completed
Location
Centre D'Étude Et de Recherchesur Le Paludisme Associé À La Grossesse Et À L'Enfance (Cerpage) Cerpage
Start Date
2014-07
Trial ID
NCT02083380
Primary Objective: To show the contribution of artefenomel (OZ439) to the ...
Status
Completed
Location
Investigational Site Number 2040001
Start Date
2018-09-11
Trial ID
NCT03660839
Treatments Being Tested
This is a single-centre, 2-part, randomised, single-dose parallel group stu...
Status
Completed
Location
Quotient Clinical
Start Date
2015-04
Trial ID
NCT02387580
Treatments Being Tested
Primary Objective: To determine whether a single dose combination of OZ439...
Status
Terminated
Location
Investigational Site Number 204001
Start Date
2015-07-25
Trial ID
NCT02497612
Treatments Being Tested